Comments on "Inhibition of estrogen actions in human gynecological malignancies: new aspects of endocrine therapy for endometrial cancer and ovarian cancer"

Mol Cell Endocrinol. 2012 Nov 5;363(1-2):131-2; author reply 133. doi: 10.1016/j.mce.2011.08.023. Epub 2011 Aug 22.

Authors

Andrea Romano¹, Gerard A J Dunselman, Johannes L H Evers, Roy F P M Kruitwagen

Affiliation

¹ GROW: School for Oncology and Developmental Biology, Dept. of Obstetrics and Gynaecology, Maastricht University Medical Centre, The Netherlands. a.romano@maastrichtuniversity.nl

PMID: 21875642
DOI: 10.1016/j.mce.2011.08.023

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use*
Endometrial Neoplasms / drug therapy*
Estrogens / metabolism*
Female
Humans
Ovarian Neoplasms / drug therapy*

Substances

Antineoplastic Agents, Hormonal
Estrogens